Leaflet: information for the patient
Bisoprolol Cor Sandoz 1.25 mg film-coated tablets
bisoprolol fumarate
Read this leaflet carefully before you start taking this medicine because
it contains important information for you.
Bisoprolol belongs to a group of medicines called beta-blockers. This group of medicines protects the heart when it has too much activity.
Bisoprolol is used to treat:
heart failure that causes difficulty breathing during physical exertion or fluid retention. In this case, bisoprolol may be used as additional treatment with other medicines for heart failure.
Do not take Bisoprolol Cor Sandoz
Consult your doctor if you are unsure about any of the above conditions.
Warnings and precautions
Inform your doctor before taking Bisoprolol Cor Sandoz
There is currently no therapeutic experience with the use of bisoprolol in the treatment of heart failure in patients with the following diseases and conditions:
The treatment of heart failure with bisoprolol requires regular medical monitoring. This is absolutely necessary, especially at the beginning of treatment and after stopping treatment.
Do not stop taking bisoprolol abruptly unless there are compelling reasons.
Consult your doctor if you have or have had any of these conditions.
Other medications and Bisoprolol Cor Sandoz
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription. Certain medications cannot be used at the same time, while others require specific changes (e.g., in dosage).
Inform your doctor if you are using or are being administered any of the following medications in addition to bisoprolol:
All these medications, like bisoprolol, can modify blood pressure and/or cardiac function.
Taking Bisoprolol Cor Sandoz and alcohol
The dizziness and headache that bisoprolol may cause can worsen if you consume alcohol. If this happens, avoid consuming alcohol.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication. Bisoprolol may have adverse effects on pregnancy and/or the fetus. There is a higher risk of premature birth, abortion, low blood sugar, and reduced neonatal heart rate. It may also affect fetal growth. Therefore, bisoprolol should not be used during pregnancy.
The passage of bisoprolol into human milk is unknown, and its use is not recommended during breastfeeding.
Driving and operating machinery
This medication may cause you to feel tired, drowsy, or dizzy. If you experience these side effects, do not drive or operate machinery. Be especially cautious at the start of treatment, with dose changes, and in combination with alcohol.
Bisoprolol Cor Sandoz contains lactose and sodium
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per coated tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many tablets to take. You should take this medication in the morning, before, during, or after breakfast. Swallow the tablets with the help of a glass of water and do not chew or crush them.
The recommended dose is:
Heart failure (reduced heart pumping force)
When starting treatment with bisoprolol, you will already be using an ACE inhibitor, a diuretic, or a cardiac glycoside (heart or blood pressure medication).
The dose will be increased gradually to reach the most suitable one for you:
1.25 mg once a day for one week. If well tolerated, the dose can be increased to:
2.5 mg once a day for another week. If well tolerated, the dose can be increased to:
3.75 mg once a day for another week. If well tolerated, the dose can be increased to:
5 mg once a day for the next 4 weeks. If well tolerated, the dose can be increased to:
7.5 mg once a day for the next 4 weeks. If well tolerated, the dose can be increased to:
10 mg once a day as maintenance dose.
The maximum daily dose is 10 mg of bisoprolol.
Your doctor will determine the optimal dose for you based on, among other things, possible side effects.
After the first dose of 1.25 mg, your doctor will check your blood pressure, heart rate, and heart function.
Liver or kidney insufficiency
Dose increases should be done with greater caution.
Advanced age
Normally, no dose adjustment is necessary.
If you estimate that the action of bisoprolol is too strong or too weak, inform your doctor or pharmacist.
Treatment duration
Generally, bisoprolol treatment is long-term.
Use in children and adolescents
There is no experience with bisoprolol in children and adolescents, so its use is not recommended in children.
If you take more Bisoprolol Cor Sandoz than you should
If you have accidentally taken more doses than your doctor prescribed,consult your doctor or pharmacist immediately. Bring the remaining tablets or this leaflet with you so that the medical team knows exactly what you have ingested. Symptoms of overdose may include dizziness, vertigo,fatigue, and/or difficulty breathing.
In addition, a reduction in heart rate, decrease in blood pressure, heart failure, and lowering of blood glucose levels (which may cause hunger, sweating, and palpitations) may occur.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Bisoprolol Cor Sandoz
Do not take a double dose to compensate for the missed doses.Take your dose as soon as you remember and then continue with the normal daily dose the next day.
If you interrupt treatment with Bisoprolol Cor Sandoz
Bisoprolol treatment should not be stopped abruptly. If you stop taking this medication suddenly, your condition may worsen. Instead, the dose should be gradually reduced over several weeks as indicated by your doctor.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
To avoid serious reactions, talk to your doctor immediately if a severe side effect occurs suddenly or worsens quickly.
The most serious side effects are related to heart function:
If you feel dizzy or weak, or have difficulty breathing, contact your doctor as soon as possible.
You should see your doctor immediately if you experience severe allergic reactions, which can occur on the face, neck, tongue, mouth, or throat, or difficulty breathing.
Other side effects are listed below according to how often they may occur:
Frequent, may affect up to 1 in 10 patients:
Rare, may affect up to 1 in 100 patients:
Rare, may affect up to 1 in 1,000 patients:
Very rare, may affect up to 1 in 10,000 patients:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister and on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not use this medication 6 months after opening the bottle.
Blister:This medication does not require special storage conditions.
Bottle:Store below 30°C.
Storage conditions after opening the bottle: Store below 25°C.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Bisoprolol Cor Sandoz
calcium hydrogen phosphate anhydrous, microcrystalline cellulose, pregelatinized maize starch, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate, lactose monohydrate, hypromellose, macrogol 4000, titanium dioxide (E 171).
Appearance of the product and contents of the package
Bisoprolol Cor Sandoz 1.25 mg are film-coated, round, white tablets with the imprint “BIS 1.25” on one of their faces.
The tablets are packaged in blisters (OPA-Al-PVC/Al) or HDPE bottles with PE corks.
Package sizes:
Blister: 7, 10, 20, 28, 30, 50, 56, 60, 90, 98, 100, 10x20 and 10x30 film-coated tablets.
Bottles: 10, 20, 30, 50, 60, 100, 250, 500 film-coated tablets.
Only some package sizes may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Responsible for manufacturing
LEK PHARMACEUTICAL COMPANY D.D.
Verovskova, 57
Ljubljana – 1526
Slovenia
SALUTAS PHARMA GMBH
Otto Von Guericke Alle, 1
Barleben D-39179
Germany
ROWA PHARMACEUTICALS LIMITED
Newtown (Bantry, Co Cork)
Ireland
LEK, S.A.
Ul Domaniewska 50 C
Warsaw - PL02-672
Poland
LEK S.A.
UI Podlipie, 16
Strykow
Poland
This medicine is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
Austria:Bisoprolol Sandoz 1.25 mg – Filmtabletten
Germany:Bisoprolol Sandoz 1.25 mg Filmtabletten
France:BISOPROLOL Sandoz 1.25 mg, comprimé pelliculé sécable
United Kingdom
(Northern Ireland):Bisoprolol Fumarate 1.25 mg film-coated Tablets
Italy:Bisoprolol Sandoz 1.25 mg compresse rivestite con film
Netherlands:Bisoprolol fumaraat Sandoz Tablet 1.25 mg, filmomhulde tabletten
Norway:Bisoprolol Sandoz
Poland:Bibloc
Sweden:Bisoprolol Sandoz
Slovenia:Byol 1.25 mg filmsko obložene tablete
Last review date of this leaflet: March 2022
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.